Medicare Enrolled
Dr. Henry Porter, M.D.
Neurology · Pensacola, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Porter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Porter?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Porter
Dr. Henry Porter is a neurology specialist in Pensacola, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Porter performed 26,655 Medicare services across 1,409 unique beneficiaries.
Between the years covered by Open Payments, Dr. Porter received a total of $33,945 from 101 pharmaceutical and/or device companies across 1627 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Porter is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 4% volume in FL
$33,945 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 45896 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗26,655
Medicare services
Top 4% in FL for neurology
1,409
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,333 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
19,708 | $5 | $31 |
| Botox injection (Xeomin), per unit An injection of incobotulinumtoxin A, a botulinum toxin type A product, administered in a quantity of one unit. |
5,149 | $4 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
945 | $91 | $546 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
396 | $120 | $832 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
120 | $60 | $376 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
63 | $127 | $803 |
| Punch biopsy of additional skin growth A small circular tool is used to remove a sample of an extra skin growth for laboratory examination. |
50 | $47 | $302 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
44 | $98 | $676 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
44 | $26 | $183 |
| Chemical nerve block injection, 1-4 muscles An injection of a chemical agent to paralyze specific muscles in an arm or leg. This procedure targets one to four muscles in the first extremity treated. |
29 | $116 | $482 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 29 | $75 | $263 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
28 | $171 | $706 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
28 | $139 | $734 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
22 | $99 | $624 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$33,945
Total received (2018-2024)
Avg $4,849/year across 7 years
Top 11% in FL for neurology
101
Companies
1,627
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,008 (88.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,937 (11.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,032
2023
$5,148
2022
$4,592
2021
$4,593
2020
$2,922
2019
$3,963
2018
$6,695
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Avanir Pharmaceuticals, Inc.
$4,065
ABBVIE INC.
$1,851
Teva Pharmaceuticals USA, Inc.
$1,418
Novartis Pharmaceuticals Corporation
$1,335
LivaNova USA, Inc.
$1,258
Biogen, Inc.
$1,143
SK Life Science, Inc.
$1,113
JAZZ PHARMACEUTICALS INC.
$1,091
UCB, Inc.
$1,058
MDD US Operations, LLC
$1,034
Lundbeck LLC
$1,000
PFIZER INC.
$988
Amgen Inc.
$965
Genentech USA, Inc.
$744
EMD Serono, Inc.
$721
Eisai Inc.
$711
Lilly USA, LLC
$578
Alexion Pharmaceuticals, Inc.
$537
CSL Behring
$478
ACADIA Pharmaceuticals Inc
$450
ARGENX US, INC.
$421
Sunovion Pharmaceuticals Inc.
$413
Acorda Therapeutics, Inc
$380
Celgene Corporation
$373
Supernus Pharmaceuticals, Inc.
$367
GENZYME CORPORATION
$349
IMPEL PHARMACEUTICALS INC.
$338
Adamas Pharmaceuticals, Inc.
$328
Neurocrine Biosciences, Inc.
$327
Jazz Pharmaceuticals Inc.
$327
Alnylam Pharmaceuticals Inc.
$325
Allergan, Inc.
$318
Otsuka America Pharmaceutical, Inc.
$313
Takeda Pharmaceuticals U.S.A., Inc.
$303
Mallinckrodt Hospital Products Inc.
$272
CATALYST PHARMACEUTICALS, INC.
$271
US WorldMeds, LLC
$269
AbbVie Inc.
$268
Axsome Therapeutics, Inc.
$261
EISAI INC.
$257
Octapharma USA, Inc.
$255
Horizon Therapeutics plc
$241
Greenwich Biosciences, Inc.
$238
Merz Pharmaceuticals, LLC
$227
Grifols USA, LLC
$191
Allergan Inc.
$185
Catalyst Pharmaceuticals, Inc.
$174
E.R. Squibb & Sons, L.L.C.
$172
Biohaven Pharmaceutical Holding Company Ltd.
$169
Akcea Therapeutics, Inc.
$159
Amneal Pharmaceuticals LLC
$155
Kyowa Kirin, Inc.
$154
Merck Sharp & Dohme LLC
$132
Merz North America, Inc.
$131
Biohaven Pharmaceuticals, Inc.
$124
Philips Electronics North America Corporation
$119
ARBOR PHARMACEUTICALS, INC.
$116
Mitsubishi Tanabe Pharma America, Inc.
$115
Impax Laboratories, Inc.
$101
Neurelis, Inc.
$100
Xeris Pharmaceuticals, Inc.
$99
Mallinckrodt Enterprises LLC
$98
AstraZeneca Pharmaceuticals LP
$96
MITSUBISHI TANABE PHARMA AMERICA, INC.
$90
Harmony Biosciences LLC
$86
Medtronic, Inc.
$70
Upsher-Smith Laboratories LLC
$69
GE HEALTHCARE
$68
Mallinckrodt LLC
$62
Boston Scientific Corporation
$57
Currax Pharmaceuticals LLC
$54
Janssen Pharmaceuticals, Inc
$54
Merck Sharp & Dohme Corporation
$47
AbbVie, Inc.
$45
HARMONY BIOSCIENCES LLC
$45
Avadel CNS Pharmaceuticals, LLC
$44
Novo Nordisk Inc
$40
Strongbridge US INC.
$40
Assertio Therapeutics, Inc.
$40
ASSERTIO THERAPEUTICS, Inc.
$38
GE Healthcare
$37
Exeltis, USA Inc.
$36
Egalet US Inc
$34
Abbott Laboratories
$33
BOSTON SCIENTIFIC CORPORATION
$29
Zyla Life Sciences, Inc.
$22
UPSHER-SMITH LABORATORIES LLC
$22
REVANCE THERAPEUTICS, INC.
$21
Averitas Pharma Inc.
$18
GE HealthCare
$18
Sumitomo Pharma America, Inc.
$17
Vertical Pharmaceuticals, LLC
$16
MERZ NORTH AMERICA, INC.
$16
Avion Pharmaceuticals
$15
Inspire Medical Systems, Inc.
$15
ANI Pharmaceuticals, Inc.
$14
SCILEX PHARMACEUTICALS INC.
$14
Zogenix Inc.
$14
PORTOLA PHARMACEUTICALS, INC.
$13
Medtronic USA, Inc.
$13
GRT US Holding, Inc.
$11
Top 3 companies account for 21.6% of total payments
Associated products mentioned in payments ›
(1305) Mask · (8207) DreamStation Cpap Core · (8211) DS Cpap Auto Core · ACTHAR · ACTIVA · ACTIVA PC · ADUHELM · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · CAMBIA · COMIRNATY · CONTRAVE · COPAXONE · CREXONT · Cambia · Cenobamate · DAXI · DUOPA · Dhivy · Duopa · EMGALITY · EPIDIOLEX · Epidiolex · Evrysdi · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · INSPIRE · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LUMRYZ · LYRICA · Leqembi · Lunoa 1 0 · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · Ocrevus · Ongentys · Ozempic · PANZYGA · PAXLOVID · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · RADICAVA · RELEXXII · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPECTRA WAVEWRITER · SPINRAZA · SPRIX · SUNOSI · Sunosi · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Tosymra Sumatriptan Nasal Spray · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VNS - Sentiva · VNS Therapy · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · Vyvanse · WELIREG · Wakix · XCOPRI · XEOMIN · XYREM · XYWAV · Xadago · Xembify · Xeomin · Xyrem · ZEPOSIA · ZTLido · Zilbrysq · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $127 per 100 Medicare services performed
Geographic Context
Neurologists within 10 mi
22
Per 100K population
6.8
County median income
$65,715
Nearest hospital
SACRED HEART HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Porter is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), with low-engagement industry engagement in the top 11% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Porter experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Porter performed 19,708 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Porter receive payments from pharmaceutical companies?
Yes. Dr. Porter received a total of $33,945 from 101 companies across 1,627 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Porter's costs compare to other neurologists in Pensacola?
Dr. Porter's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Porter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Pensacola
Browse neurologists in Pensacola ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
Avanir Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Avanir Pharmaceuticals, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology